FDA Names New Acting Vaccine Leader After Previous Chief’s Departure

Scott Steele was named acting head. Peter Marks left the position last month over what he saw as HHS Secretary Kennedy’s ’misinformation and lies.’

A girl receives a COVID-19 vaccine from a nurse at the University of Miami Health System's pediatric mobile clinic in Miami on May 17, 2021. Joe Raedle/Getty Images

After its top vaccine official left the Food and Drug Administration (FDA), the agency announced Tuesday that it has named his replacement.

In an April 1 statement on X, the FDA said Scott Steele would be the acting head of the Center for Biologics Evaluation and Research (CBER), which Peter Marks once led.